A federal judge in Boston on Tuesday directed the Trump administration to restore the legal status of migrants allowed into the U.S. under a now-defunct Biden administration program for asylum-seekers ...

Something to look forward to: Microsoft released new Windows 11 Insider Preview builds to the Canary, Dev, and Beta channels this week, bringing multiple new features for developers and power users.

Gen. Stephen Whiting noted the number of personnel at Redstone is expected to grow to nearly 200 by the end of 2026. (Staff Sgt. Kirsten Brandes/U.S. Space Force) U.S. Space Command is operating a ...

For the 49th Cooper River Bridge Run, Charleston and Mount Pleasant authorities closed some roads along the route. The 10K started at 8 a.m. in Mount Pleasant, with participants traversing the Arthur ...

ANN ARBOR – Holy Cross’ women’s basketball team entered Friday’s NCAA Tournament first-round matchup against Michigan as a major underdog, but it wasn’t lacking confidence. The Crusaders (23-10), who ...

Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. Dany Lepage discusses the architectural ...

Forbes contributors publish independent expert analyses and insights. I write about biodiversity and the hidden quirks of the natural world. This voice experience is generated by AI. Learn more. This ...

Andrew Kahn didn’t bury the lead on the latest episode of Wolverine Confidential: “Their record is 24-5. They’ve never had more wins or fewer losses in the regular season and never this many wins in ...

The Army will kick off its new retention bonus system next month, using physical fitness scores, technical expertise and commander evaluations to determine a soldier’s payout to reenlist. “We were ...

PHOENIX — Grand Canyon University is partnering with the Taiwan Semiconductor Manufacturing Co. for an industry-funded 11-week course that could end in a job offer with TSMC Arizona. The program began ...

Two new cancer cases have prompted Kyowa Kirin to shutter all clinical studies of its investigational anti-OX40 monoclonal antibody designed to treat inflammatory diseases. The discontinuation will ...